glp 1 agonist in ckd Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation GLP-1 receptor agonists and next-generation
Description
Suppresses Glucagon Secretion: It also acts on the alpha cells of the pancreas to reduce the secretion of glucagon, a hormone that tells the liver to release stored glucose
Medical Writing and Editorial Assistance The authors acknowledge Preethi Seshadri, PhD, and Rajani Salunke, PhD, of Indegene Pvt
Todd Norwood, Clinical MSK, Omada Health, San Francisco, CA, United States
Always discuss combination approaches with your prescriber
A p-value of less than 0.05 was set as the threshold for clinical significance
Lixisenatide, a GLP-1R agonist, reduces neurofibrillary tangles and amyloid plaque load, and thereby ameliorates learning memory deficits in APP/PS1 mice (144, 157)
